These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 6226239
1. Mechanisms of T-cell unresponsiveness in leprosy. Bach MA, Hoffenbach A, Lagrange PH, Wallach D, Cottenot F. Ann Immunol (Paris); 1983; 134D(1):75-84. PubMed ID: 6226239 [Abstract] [Full Text] [Related]
2. In vitro proliferative response to M. leprae and PPD of isolated T cell subsets from leprosy patients. Bach MA, Wallach D, Flageul B, Cottenot F. Clin Exp Immunol; 1983 Apr; 52(1):107-14. PubMed ID: 6345031 [Abstract] [Full Text] [Related]
3. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy. Shankar P, Agis F, Wallach D, Flageul B, Cottenot F, Augier J, Bach MA. J Immunol; 1986 Jun 01; 136(11):4255-63. PubMed ID: 2422278 [Abstract] [Full Text] [Related]
4. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy. Garraud O, Ribierre O, Bach MA. Int J Lepr Other Mycobact Dis; 1986 Mar 01; 54(1):38-45. PubMed ID: 2940306 [Abstract] [Full Text] [Related]
5. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients. Mutis T, Kraakman EM, Cornelisse YE, Haanen JB, Spits H, De Vries RR, Ottenhoff TH. J Immunol; 1993 May 15; 150(10):4641-51. PubMed ID: 8482851 [Abstract] [Full Text] [Related]
6. Mycobacterium leprae antigen-induced suppression of T cell proliferation in vitro. Kaplan G, Gandhi RR, Weinstein DE, Levis WR, Patarroyo ME, Brennan PJ, Cohn ZA. J Immunol; 1987 May 01; 138(9):3028-34. PubMed ID: 3106496 [Abstract] [Full Text] [Related]
7. Defective cell-mediated immunity in leprosy: failure of T cells from lepromatous leprosy patients to respond to Mycobacterium leprae is associated with defective expression of interleukin 2 receptors and is not reconstituted by interleukin 2. Mohagheghpour N, Gelber RH, Larrick JW, Sasaki DT, Brennan PJ, Engleman EG. J Immunol; 1985 Aug 01; 135(2):1443-9. PubMed ID: 2989366 [Abstract] [Full Text] [Related]
10. Studies on T cell subsets and functions in leprosy. Bach MA, Chatenoud L, Wallach D, Phan Dinh Tuy F, Cottenot F. Clin Exp Immunol; 1981 Jun 01; 44(3):491-500. PubMed ID: 6459897 [Abstract] [Full Text] [Related]
11. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type. Laal S, Mishra RS, Nath I. Int J Lepr Other Mycobact Dis; 1987 Sep 01; 55(3):481-93. PubMed ID: 2958570 [Abstract] [Full Text] [Related]
12. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants. Reitan LJ, Closs O, Belehu A. Int J Lepr Other Mycobact Dis; 1982 Dec 01; 50(4):455-67. PubMed ID: 6763003 [Abstract] [Full Text] [Related]
13. Concanavalin A induced suppressor activity in human leprosy. Nath I, Narayanan RB, Mehra NK, Sharma AK, Gupte MD. J Clin Lab Immunol; 1979 Nov 01; 2(4):319-24. PubMed ID: 161322 [Abstract] [Full Text] [Related]
14. In vivo responses to Mycobacterium leprae: antigen presentation, interleukin-2 production, and immune cell phenotypes in naturally occurring leprosy lesions. Longley J, Haregewoin A, Yemaneberhan T, Warndorff van Diepen T, Nsibami J, Knowles D, Smith KA, Godal T. Int J Lepr Other Mycobact Dis; 1985 Sep 01; 53(3):385-94. PubMed ID: 3900245 [Abstract] [Full Text] [Related]
15. Genetic control of murine T cell proliferative responses to Mycobacterium leprae. V. Evidence for cross-reactivity between host antigens and Mycobacterium leprae. Harris DP, Jones AG, Wade S, Krahenbuhl JL, Gillis TP, Watson JD. J Immunol; 1988 Sep 01; 141(5):1695-700. PubMed ID: 2970509 [Abstract] [Full Text] [Related]
16. Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells. Ottenhoff TH, Elferink DG, Klatser PR, de Vries RR. Nature; 1988 Sep 01; 322(6078):462-4. PubMed ID: 2426597 [Abstract] [Full Text] [Related]
17. Limiting dilution analysis of the human T cell response to mycobacterial antigens from BCG vaccinated individuals and leprosy patients. Brett SJ, Kingston AE, Colston MJ. Clin Exp Immunol; 1987 Jun 01; 68(3):510-20. PubMed ID: 3308217 [Abstract] [Full Text] [Related]
18. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors. Mohagheghpour N, Gelber RR, Engleman EG. J Immunol; 1987 Jan 15; 138(2):570-4. PubMed ID: 2947952 [Abstract] [Full Text] [Related]
19. ConA-induced suppressor cells in lepromatous leprosy patients during and after erythema nodosum leprosum. Sasiain MC, Ruibal Ares B, Baliña LM, Valdez R, Bachmann AE. Int J Lepr Other Mycobact Dis; 1983 Sep 15; 51(3):321-7. PubMed ID: 6227570 [Abstract] [Full Text] [Related]
20. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy. Nath I, Singh R. Clin Exp Immunol; 1980 Sep 15; 41(3):406-14. PubMed ID: 7002396 [Abstract] [Full Text] [Related] Page: [Next] [New Search]